Related references
Note: Only part of the references are listed.MRI measures of neurodegeneration in multiple sclerosis: implications for disability, disease monitoring, and treatment
Massimo Filippi
JOURNAL OF NEUROLOGY (2015)
Clinical Relevance of Brain Volume Measures in Multiple Sclerosis
Nicola De Stefano et al.
CNS DRUGS (2014)
Magnetic resonance outcome measures in multiple sclerosis trials: time to rethink?
Massimo Filippi et al.
CURRENT OPINION IN NEUROLOGY (2014)
Placebo-controlled trial of oral laquinimod in multiple sclerosis: MRI evidence of an effect on brain tissue damage
Massimo Filippi et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2014)
Differential effects of fingolimod on B-cell populations in multiple sclerosis
Masakazu Nakamura et al.
MULTIPLE SCLEROSIS JOURNAL (2014)
Wallerian and trans-synaptic degeneration contribute to optic radiation damage in multiple sclerosis: a diffusion tensor MRI study
Maria A. Rocca et al.
MULTIPLE SCLEROSIS JOURNAL (2013)
Early brain pseudoatrophy while on natalizumab therapy is due to white matter volume changes
Angela Vidal-Jordana et al.
MULTIPLE SCLEROSIS JOURNAL (2013)
The acute phase of Wallerian degeneration: Longitudinal diffusion tensor imaging of the fornix following temporal lobe surgery
Min Liu et al.
NEUROIMAGE (2013)
Effect of disease-modifying drugs on cortical lesions and atrophy in relapsing-remitting multiple sclerosis
M. Calabrese et al.
MULTIPLE SCLEROSIS JOURNAL (2012)
Multivariate pattern classification of gray matter pathology in multiple sclerosis
Kerstin Bendfeldt et al.
NEUROIMAGE (2012)
Effect of immunomodulatory medication on regional gray matter loss in relapsing-remitting multiple sclerosis-A longitudinal MRI study
Kerstin Bendfeldt et al.
BRAIN RESEARCH (2010)
Lamotrigine for neuroprotection in secondary progressive multiple sclerosis: a randomised, double-blind, placebo-controlled, parallel-group trial
Raju Kapoor et al.
LANCET NEUROLOGY (2010)
Focal and diffuse cortical degenerative changes in a marmoset model of multiple sclerosis
I. M. Pomeroy et al.
MULTIPLE SCLEROSIS JOURNAL (2010)
Demyelination, Inflammation, and Neurodegeneration in Multiple Sclerosis Deep Gray Matter
Marco Vercellino et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2009)
Gray matter atrophy and disability progression in patients with early relapsing-remitting multiple sclerosis A 5-year longitudinal study
Dana Horakova et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2009)
Segmentation of brain magnetic resonance images for measurement of gray matter atrophy in multiple sclerosis patients
Kunio Nakamura et al.
NEUROIMAGE (2009)
Origins of the BOLD post-stimulus undershoot
Jean J. Chen et al.
NEUROIMAGE (2009)
Gray-Matter Injury in Multiple Sclerosis
Richard A. Rudick et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Gray matter atrophy in multiple sclerosis: A longitudinal study
Elizabeth Fisher et al.
ANNALS OF NEUROLOGY (2008)
Gray matter atrophy is related to long-term disability in multiple sclerosis
Leonora K. Fisniku et al.
ANNALS OF NEUROLOGY (2008)
Evolution of different MRI measures in patients with active relapsing-remitting multiple sclerosis over 2 and 5 years: a case-control study
D. Horakova et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2008)
Association of neocortical volume changes with cognitive deterioration in relapsing-remitting multiple sclerosis
Maria Pia Amato et al.
ARCHIVES OF NEUROLOGY (2007)
Interferon beta-1 a slows progression of brain atrophy in relapsing-remitting multiple sclerosis predominantly by reducing gray matter atrophy
R. Zivadinov et al.
MULTIPLE SCLEROSIS JOURNAL (2007)
Atlas-based fuzzy connectedness segmentation and intensity nonuniformity correction applied to brain MRI
Yongxin Zhou et al.
IEEE TRANSACTIONS ON BIOMEDICAL ENGINEERING (2007)
Brain atrophy and lesion load in a large population of patients with multiple sclerosis
G Tedeschi et al.
NEUROLOGY (2005)
The relationship between whole brain volume and disability in multiple sclerosis: A comparison of normalized gray vs. white matter with misclassification correction
MP Sanfilipo et al.
NEUROIMAGE (2005)
Cortical lesions and brain atrophy in MS
A Kutzelnigg et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2005)
Gray and white matter volume changes in early RRMS - A 2-year longitudinal study
M Tiberio et al.
NEUROLOGY (2005)
Effect of natalizumab on conversion of gadolinium enhancing lesions to T1 hypointense lesions in relapsing multiple sclerosis
CM Dalton et al.
JOURNAL OF NEUROLOGY (2004)
Progressive grey matter atrophy in clinically early relapsing-remitting multiple sclerosis
DT Chard et al.
MULTIPLE SCLEROSIS JOURNAL (2004)
Subpial demyelination in the cerebral cortex of multiple sclerosis patients
L Bo et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2003)
Share Paper
